Application Detail

Description of Medical Service

The IPAC Project assessed the outcomes associated with integrating pharmacists providing medication management services into Aboriginal Community Controlled Health Services (ACCHSs) compared with usual care (pre-intervention).

Description of Medical Condition

The IPAC trial recruited regular clients of ACCHSs who had a diagnosis of:

• Cardiovascular disease (coronary heart disease, stroke, hypertension, dyslipidaemia and any other cardiovascular disease),
• Type 2 diabetes mellitus,
• Chronic kidney disease, or
• Other chronic conditions and at high risk of developing medication-related problems (e.g. polypharmacy).

Reason for application

The Sixth Community Pharmacy Agreement provided funding to support a Pharmacy Trial Program (PTP), which seeks to improve clinical outcomes for patients and/or utilise the full scope of a pharmacist’s role in delivering primary health care services.

The outcomes of all PTP Trials will undergo an independent health technology assessment to determine the effectiveness and cost-effectiveness of the trial intervention and inform decisions about any broader rollout. A decision to fund any future programs would be a matter for Government.

Information on the PTP is available on the Department of Health’s website.

Medical Service Type

Therapeutic technology

Previous Application Number

Not applicable

Associated Documentation

IPAC Public Summary

IPAC Public Summary (PDF 1307 KB)
IPAC Public Summary (Word 695 KB)

Consultation Survey

Consultation Survey (PDF 573 KB)
Consultation Survey (Word 76 KB)

MSAC welcomes public consultation input as per the IPAC Public Summary above.

Please send feedback on this application to commentsMSAC@health.gov.au (and cc: pharmacy.trial.program@health.gov.au) including the MSAC application number 1678 in the subject heading of your email.

PASC Consultation
Not applicable

MSAC Consultation
MSAC consultation closed 11 February 2022.

For further information please refer to PASC, ESC, MSAC Key Dates
For further information on the consultation process please refer to MSAC Consultation Process

PICO Confirmation

Not applicable

Assessment Report

-

Public Summary Document

Public Summary Document (PDF 636 KB)
Public Summary Document (Word 170 KB)

Meetings for this Application

PASC

Bypassing PASC

ESC

10-11 February 2022

MSAC

31 March–1 April 2022

Stakeholder Meeting

Monday 10 October 2022, members of MSAC, representatives of the applicant from the Pharmaceutical Society of Australia, National Aboriginal Community Controlled Health Organisation (NACCHO) and James Cook University; representatives from Aboriginal Health Services (AHS) and Aboriginal Community Controlled Health Services (ACCHS); representatives from the Northern Territory Health Service; and representatives from the Department of Health and Aged Care met to discuss Integrating Pharmacists within Aboriginal Community Controlled Health Services to Improve Chronic Disease Management (IPAC Project). This was not an MSAC decision forum, but a meeting to seek stakeholder input on issues raised by MSAC during its March-April 2022 consideration of Application 1678 – IPAC Project. The final minutes of this meeting are below.

Final Stakeholder Meeting Minutes (PDF 257 KB)
Final Stakeholder Meeting Minutes (Word 66 KB)